Hematology laboratory shift based on common terminology criteria in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study. J of Skin [Internet]. 2023 Mar. 13 [cited 2025 Apr. 19];7(2):s180. Available from: https://skin.dermsquared.com/skin/article/view/2010